| |
|
|
|
Leap Therapeutics Inc
|
|
5.69 +0.70 (+14.03%) |
10/20/2017 3:59pm |
|
Open: |
5.07 |
Pre close: |
4.99 |
Target:
|
6.87 
|
|
High: |
5.72 |
Low: |
4.91 |
Resistance:
|
5.88
6.87
|
|
Volume: |
51,060 |
Market Cap: |
53.46M |
Support:
|
5.27
4.90
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.17
|
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
5.39 |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
6.17  |
Stochastic Oscillator |
%K(14,3):
|
33.12 |
|
MA(250): |
0.00 |
%D(3): |
20.56 |
|
Average Volume(K) |
3-Month: |
2235
|
52-Week |
High:
|
10.10 |
|
10-Days: |
355 |
Low: |
4.90 |
|
RSI |
RSI(14):
|
54.85 |
Change(%): |
-27.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.150 |
Return on Equity (ttm) |
-4400.1 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-3.160 |
Return on Assets (ttm) |
-134.6 |
Shares Float (M) |
3.26 |
|
EPS Est. Next Year |
-3.090 |
PEG Ratio |
0.67 |
% Held by Insiders |
7.00 |
|
EPS Est. Next Quarter |
-0.630 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
59.22 |
|
Forward EPS |
-3.086 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
25 |
|
Book Value (p.s.) |
1.950 |
EBITDA (p.s.) |
-3.015 |
P/E |
-1.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-17.42 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
